首页> 美国卫生研究院文献>International Journal of Otolaryngology >The Lyon Clinical Olfactory Test: Validation and Measurement of Hyposmia and Anosmia in Healthy and Diseased Populations
【2h】

The Lyon Clinical Olfactory Test: Validation and Measurement of Hyposmia and Anosmia in Healthy and Diseased Populations

机译:里昂临床嗅觉测试:健康和患病人群的低氧血症和失眠症的验证和测量

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The LCOT is a self-administered test designed to assess olfactory deficits. Altogether, 525 subjects contributed to the validation. Elderly participants were well represented in this sample. In a validation study (study 1), 407 healthy and 17 anosmic volunteers between 15 and 91 years of age underwent threshold, supraliminal detection, and identification testing. Cutoff values for normosmia and hyposmia were calculated and applied in a second study in a group of patients with smell complaints and in a group of Alzheimer patients with age-matched controls. Incidence of smell deficit was estimated at 5.6% in the healthy population of study 1, and at 16% in the elderly control group of study 2. Assessment of the ability of each subtest to discriminate between groups showed that LCOT is relevant to differentiating between perception and identification deficits and between Alzheimer's and hyposmic patients.
机译:LCOT是一种自我管理的测试,旨在评估嗅觉缺陷。共有525个主题为验证做出了贡献。老年参与者在该样本中得到了很好的体现。在一项验证研究(研究1)中,对407名健康的和17名年龄在15至91岁之间的厌氧志愿者进行了阈值,ral上检测和鉴定测试。计算出常态和低渗的临界值,并将其用于第二项研究中,用于一组有异味的患者和一组年龄匹配的阿尔茨海默病患者。在研究1的健康人群中,嗅觉缺陷的发生率估计为5.6%,在研究2的老年对照组中为16%。评估每个子测试区分组的能力表明,LCOT与区分感知力有关和识别缺陷,以及阿尔茨海默氏病和低氧患者之间的差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号